Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.

Faruki H, Mayhew GM, Serody JS, Hayes DN, Perou CM, Lai-Goldman M.

J Thorac Oncol. 2017 Mar 21. pii: S1556-0864(17)30214-9. doi: 10.1016/j.jtho.2017.03.010. [Epub ahead of print]

PMID:
28341226
2.

Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.

Faruki H, Mayhew GM, Fan C, Wilkerson MD, Parker S, Kam-Morgan L, Eisenberg M, Horten B, Hayes DN, Perou CM, Lai-Goldman M.

Arch Pathol Lab Med. 2016 Jun;140(6):536-42. doi: 10.5858/arpa.2015-0113-OA. Epub 2015 Oct 2.

PMID:
26430809
3.

Implementation of a pharmacogenomics service in a community pharmacy.

Ferreri SP, Greco AJ, Michaels NM, O'Connor SK, Chater RW, Viera AJ, Faruki H, McLeod HL, Roederer MW.

J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):172-80. doi: 10.1331/JAPhA.2014.13033.

PMID:
24632932
4.

Cystic fibrosis carrier screening in a North American population.

Zvereff VV, Faruki H, Edwards M, Friedman KJ.

Genet Med. 2014 Jul;16(7):539-46. doi: 10.1038/gim.2013.188. Epub 2013 Dec 19.

PMID:
24357848
5.

Genomic testing: the clinical laboratory perspective.

Faruki H.

Clin Pharmacol Ther. 2013 Aug;94(2):190-2. doi: 10.1038/clpt.2013.61.

PMID:
23872833
6.

Making pharmacogenetic testing a reality in a community pharmacy.

O'Connor SK, Ferreri SP, Michaels NM, Chater RW, Viera AJ, Faruki H, McLeod HL, Roederer M.

J Am Pharm Assoc (2003). 2012;52(6):e259-65. doi: 10.1331/JAPhA.2012.12108.

PMID:
23229988
7.

Effective communication of molecular genetic test results to primary care providers.

Scheuner MT, Edelen MO, Hilborne LH, Lubin IM; RAND Molecular Genetic Test Report Advisory Board..

Genet Med. 2013 Jun;15(6):444-9. doi: 10.1038/gim.2012.151. Epub 2012 Dec 6.

PMID:
23222660
8.

A report template for molecular genetic tests designed to improve communication between the clinician and laboratory.

Scheuner MT, Hilborne L, Brown J, Lubin IM; members of the RAND Molecular Genetic Test Report Advisory Board..

Genet Test Mol Biomarkers. 2012 Jul;16(7):761-9. doi: 10.1089/gtmb.2011.0328. Epub 2012 Jun 25.

PMID:
22731646
9.

Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.

O'Connor SK, Ferreri SP, Michaels NM, Greco AJ, Viera AJ, Faruki H, McLeod HL, Roederer MW.

Pharmacogenomics. 2012 Jun;13(8):955-62. doi: 10.2217/pgs.12.67.

10.

Hepatitis C pharmacogenetics: state of the art in 2010.

Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, Goldstein DB; Pharmacogenetics and Hepatitis C Meeting Participants..

Hepatology. 2011 Jan;53(1):336-45. doi: 10.1002/hep.24052. Review.

PMID:
21254181
11.

Abacavir hypersensitivity: a model system for pharmacogenetic test adoption.

Lai-Goldman M, Faruki H.

Genet Med. 2008 Dec;10(12):874-8. doi: 10.1097/GIM.0b013e31818de71c. Review.

PMID:
19092439
12.

HLA-B*5701 clinical testing: early experience in the United States.

Faruki H, Heine U, Brown T, Koester R, Lai-Goldman M.

Pharmacogenet Genomics. 2007 Oct;17(10):857-60.

PMID:
17885623
13.

Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level.

Parikh UM, Barnas DC, Faruki H, Mellors JW.

J Infect Dis. 2006 Sep 1;194(5):651-60. Epub 2006 Jul 24.

PMID:
16897664
14.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
15.

Update on HIV resistance and resistance testing.

Sebastian J, Faruki H.

Med Res Rev. 2004 Jan;24(1):115-25. Review.

PMID:
14595674
16.

HIV resistance testing: methods, utility, and limitations.

Alcorn TM, Faruki H.

Mol Diagn. 2000 Sep;5(3):159-68. Review.

PMID:
11070150
17.

Arterial thromboembolic events in patients with the factor V Leiden mutation.

Eskandari MK, Bontempo FA, Hassett AC, Faruki H, Makaroun MS.

Am J Surg. 1998 Aug;176(2):122-5.

PMID:
9737615
18.

Peripheral retinal neovascularization (Eales disease) associated with the factor V Leiden mutation.

Eller AW, Bontempo FA, Faruki H, Hassett AC.

Am J Ophthalmol. 1998 Jul;126(1):146-9.

PMID:
9683168
19.

Heterosexual HIV-1 transmission and viral load in hemophilic patients.

Ragni MV, Faruki H, Kingsley LA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1;17(1):42-5.

PMID:
9436757
20.

Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B.

Van Thiel DH, Friedlander L, Kania RJ, Molloy PJ, Hassanein T, Wahlstrom E, Faruki H.

Hepatogastroenterology. 1997 May-Jun;44(15):808-12.

PMID:
9222695

Supplemental Content

Loading ...
Support Center